
Why and how is PharmEasy getting funded so much?

Talking product sense with Ridhi
9 min AI interview5 questions

It's (API Holdings) getting funded at 90% de-value. Their parent company is pulled down in terms of profitability only because of its B2C arm i.e PharmEasy which is doing better than ever before (although has much lesser set of orders fulfilled - gotten rid of bad discount hungry customers).
The diagnostics arm is also a profitable one, given the margins in diag are crazy high.
PharmEasy has gotten rid of folks who were overpaid (which is continued in startups in general).
B2B folks know to make dhandha here. Hopefully works out for B2C soon.
- an ex-employee

How is culture with Kinara Capital? Somehow it's not in anyone's talk so far

🧢

90% downround Pharmeasy
Horrific scenes in the Indian startup ecosystem. From being on the verge of an IPO to raising an emergency round which shall lead to the sudden death of employee ESOPs. Crores of wealth destroyed for the employees.
A chain reaction of h...

CTC= fixed pay. That's your main course. Sometimes you get variable pay, that's dessert. Sometimes (more chance of an...

PharmEasy's Valuation Plummets to $458 Million
- API Holdings, PharmEasy's parent company, now valued at $458 million, a 92% drop from its 2021 peak.
- Janus Henderson, a key investor, slashed its valuation by 91.8%, as per SEC filings.
- In April, PharmEasy faced a 90% valuation cut...


Key takeaways from Prosus 2024 Annual Report
Most of us are curious of how decisions are made in major VC funds, as these funds are private and only share this information with their Limited Partners (LPs).
For the unknown, there are VC funds known as Corporate Venture Capital f...